CYP1A1 MspI polymorphism and acute myeloid leukemia risk: Meta-analyses based on 5018 subjects

Journal of Experimental and Clinical Cancer Research

Volumn 31, Issue 1, 2012, Pages

  Zhuo, Wenlei ^a   Zhang, Liang ^a   Wang, Yan ^a   Zhu, Bo ^a   Chen, Zhengtang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Acute myeloid leukemia; CYP1A1 MspI; Malignancy; Meta analysis; Polymorphism; Susceptibility

Indexed keywords

CYTOCHROME P450 1A1;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; ASIAN; CANCER RISK; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHILD; CYTOCHROME P-450 CYP1A1; DEOXYRIBONUCLEASE HPAII; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84864352533     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-31-62     Document Type: Article

References (42)

1. Risk factors and primary prevention of acute leukemia. Ilhan G, Karakus S, Andic N, Asian Pacific journal of cancer prevention: APJCP 2006 7 515 517 17250419
2. A meta-analysis of MTHFR C677T and A1298C polymorphisms and risk of acute lymphoblastic leukemia in children. Yan J, Yin M, Dreyer ZE, Scheurer ME, Kamdar K, Wei Q, Okcu MF, Pediatric blood & cancer 2012 58 513 518 10.1002/pbc.23137 22966030
3. Glutathione s-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: a systematic review and meta-analysis. Ye Z, Song H, European journal of cancer (Oxford, England: 1990) 2005 41 980 989 10.1016/j.ejca.2005.01.014
4. X-Ray Repair Cross-Complementing Group 1 (XRCC1) Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia: A Meta-Analysis. Wang L, Yin F, Xu X, Hu X, Zhao D, PloS one 2012 7 34897 10.1371/journal.pone.0034897 22529951
5. Methionine synthase A2756G polymorphism and cancer risk: a meta-analysis. Yu K, Zhang J, Dou C, Gu S, Xie Y, Mao Y, Ji C, European journal of human genetics: EJHG 2010 18 370 378 10.1038/ejhg.2009.131 19826453
6. Biomarkers in cancer epidemiology: an integrative approach. Boffetta P, Carcinogenesis 2010 31 121 126 10.1093/carcin/bgp269 19959558
7. Activation of procarcinogens by human cytochrome P450 enzymes. Guengerich FP, Shimada T, Mutation research 1998 400 201 213 10.1016/S0027-5107(98)00037-2 9685642
8. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Zhou SF, Liu JP, Chowbay B, Drug metabolism reviews 2009 41 89 295 10.1080/03602530902843483 19514967
9. Assessing publication bias in genetic association studies: evidence from a recent meta-analysis. Munafo MR, Clark TG, Flint J, Psychiatry research 2004 129 39 44 10.1016/j.psychres.2004.06.011 15572183
10. Bias in meta-analysis detected by a simple, graphical test. Egger M, Davey Smith G, Schneider M, Minder C, BMJ 1997 315 629 634 10.1136/bmj.315.7109. 629 9310563
11. A case-only study of interactions between metabolic enzyme polymorphisms and industrial pollution in childhood acute leukemia. Yang Y, Tian Y, Jin X, Yan C, Jiang F, Zhang Y, Tang J, Shen X, Environmental toxicology and pharmacology 2009 28 161 166 10.1016/j.etap.2009.03.004 21783998
12. CYP1A1 polymorphisms modify overall survival in acute myeloid leukemia patients. Pelloso LA, Da Silva ID, De Souza NC, Yamamoto M, Botelho CA, Chauffaille Mde L, Leukemia & lymphoma 2007 48 1211 1215 10.1080/10428190701332431 22966019
13. The GST deletions and NQO1*2 polymorphism confers interindividual variability of response to treatment in patients with acute myeloid leukemia. Barragan E, Collado M, Cervera J, Martin G, Bolufer P, Roman J, Sanz MA, Leukemia research 2007 31 947 953 10.1016/j.leukres.2006.10.002 17118447
14. The CYP1A1*2a allele is an independent prognostic factor for acute myeloid leukemia. Voso MT, D'Alo F, Gumiero D, Guidi F, Hohaus S, Leone G, Haematologica 2005 90 982 984 15996939
15. Parental smoking, CYP1A1 genetic polymorphisms and childhood leukemia (Quebec, Canada). Infante-Rivard C, Krajinovic M, Labuda D, Sinnett D, Cancer causes & control: CCC 2000 11 547 553 10.1023/A:1008976116512 22966221
16. Study on the relationship between polymorphisms of Cyp1A1, GSTM1, GSTT1 genes and the susceptibility to acute leukemia in the general population of Hunan province. Liu QX, Chen HC, Liu XF, Cao YF, Zhang J, Liu J, Zhonghua liu xing bing xue za zhi 2005 26 975 979 16676594
17. Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility. Chen HC, Hu WX, Liu QX, Li WK, Chen FZ, Rao ZZ, Liu XF, Luo YP, Cao YF, European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation (ECP) 2008 17 251 258 10.1097/CEJ.0b013e3282b72093
18. Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia. Bolufer P, Collado M, Barragan E, Calasanz MJ, Colomer D, Tormo M, Gonzalez M, Brunet S, Batlle M, Cervera J, Sanz MA, British journal of haematology 2007 136 590 596 10.1111/j.1365-2141.2006.06469.x 17367411
19. The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia. Bolufer P, Collado M, Barragan E, Cervera J, Calasanz MJ, Colomer D, Roman-Gomez J, Sanz MA, Haematologica 2007 92 308 314 10.3324/haematol.10752 17339179
20. Association of GSTT1 polymorphism with acute myeloid leukemia risk is dependent on smoking status. Kim HN, Kim NY, Yu L, Tran HT, Kim YK, Lee IK, Shin MH, Park KS, Choi JS, Kim HJ, Leukemia & lymphoma 2012 53 681 687 10.3109/10428194.2011.625576 22966019
21. Maternal smoking during pregnancy, genetic polymorphisms of metabolic enzymes, and childhood acute leukemia: the ESCALE study (SFCE). Bonaventure A, Goujon-Bellec S, Rudant J, Orsi L, Leverger G, Baruchel A, Bertrand Y, Nelken B, Pasquet M, Michel G, et al. Cancer causes & control: CCC 2012 23 329 345 10.1007/s10552-011-9882-9 22966221
22. High risk of 'de novo' acute myeloid leukaemia in individuals with cytochrome P450 A1 (CYP1A1) and NAD(P)H:quinone oxidoreductase 1 (NQO1) gene defects. Yamaguti GG, Lourenco GJ, Costa FF, Lima CS, European journal of haematology 2009 83 270 272 10.1111/j.1600-0609.2009.01272.x 19456854
23. Association of cytochrome P450, glutathione S-transferase and N-acetyl transferase 2 gene polymorphisms with incidence of acute myeloid leukemia. Majumdar S, Mondal BC, Ghosh M, Dey S, Mukhopadhyay A, Chandra S, Dasgupta UB, European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation (ECP) 2008 17 125 132 10.1097/CEJ. 0b013e3282b6fd68
24. Association between the polymorphisms of cytochrome P4501A1 and glutathione S-transferase M1, T1 Genes and acute myeloid leukemia in Guangxi. Jiang L, Chen M, Qin G, Guangxi Medical Journal 2008 30 464 466
25. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias. Aydin-Sayitoglu M, Hatirnaz O, Erensoy N, Ozbek U, American journal of hematology 2006 81 162 170 10.1002/ajh.20434 16493615
26. Polymorphisms of CYP1A1 and glutathione S-transferase and susceptibility to adult acute myeloid leukemia. D'Alo F, Voso MT, Guidi F, Massini G, Scardocci A, Sica S, Pagano L, Hohaus S, Leone G, Haematologica 2004 89 664 670 15194533
27. Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia. Balta G, Yuksek N, Ozyurek E, Ertem U, Hicsonmez G, Altay C, Gurgey A, American journal of hematology 2003 73 154 160 10.1002/ajh.10339 12827651
28. Childhood leukaemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee and alcohol consumption during pregnancy. Clavel J, Bellec S, Rebouissou S, Menegaux F, Feunteun J, Bonaiti-Pellie C, Baruchel A, Kebaili K, Lambilliotte A, Leverger G, et al. European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation (ECP) 2005 14 531 540 10.1097/00008469-200512000- 00007
29. Measuring inconsistency in meta-analyses. Higgins JP, Thompson SG, Deeks JJ, Altman DG, BMJ 2003 327 557 560 10.1136/bmj.327.7414.557 12958120
30. Assessing the influence of a single study in the meta-analysis estimate. Tobias A, Stata Techn Bull 1999 8 15 17
31. Polymorphisms of CYP1A1 and GSTM1 and laryngeal cancer risk: evidence-based meta-analyses. Zhuo WL, Wang Y, Zhuo XL, Zhu B, Zhu Y, Chen ZT, Journal of cancer research and clinical oncology 2009 135 1081 1090 10.1007/s00432-009-0548-x 19252926
32. CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis. Shaik AP, Jamil K, Das P, Urology journal 2009 6 78 86 19472123
33. CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review. Zhan P, Wang Q, Qian Q, Wei SZ, Yu LK, Journal of experimental & clinical cancer research: CR 2011 30 99 10.1186/1756-9966-30- 99 22966495
34. Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and cervical cancer risk: a meta-analysis. Sergentanis TN, Economopoulos KP, Choussein S, Vlahos NF, Molecular biology reports 2012
35. Association studies of CYP1A1 and GSTM1 polymorphisms with esophageal cancer risk: evidence-based meta-analyses. Zhuo WL, Zhang YS, Wang Y, Zhuo XL, Zhu B, Cai L, Chen ZT, Archives of medical research 2009 40 169 179 10.1016/j.arcmed.2009.01.003 19427967
36. Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis. Sergentanis TN, Economopoulos KP, Breast cancer research and treatment 2010 122 459 469 10.1007/s10549-009-0694-5 20035380
37. Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis. Zheng Y, Wang JJ, Sun L, Li HL, Molecular biology reports 2012 39 3533 3540 10.1007/s11033-011-1126-2 21710246
38. Quantitative assessment of the associations between CYP1A1 polymorphisms and gastric cancer risk. Tumour biology. Guo R, Guo X, the journal of the International Society for Oncodevelopmental Biology and Medicine 2012
39. Meta-analysis of cytochrome P4501A1 MspI gene polymorphism and childhood acute leukemia. Zhang YD, Tan LN, Zhang XL, Wei HY, Xiong H, Hu Q, Biomedical and environmental sciences: BES 2011 24 683 687 22365406
40. Racial differences in presentation, referral and treatment patterns and survival in adult patients with acute myeloid leukemia: a single-institution experience. Bierenbaum J, Davidoff AJ, Ning Y, Tidwell ML, Gojo I, Baer MR, Leukemia research 2012 36 140 145 10.1016/j.leukres.2011.10.018 22112974
41. Parental age, family size, and offspring's risk of childhood and adult acute leukemia. Larfors G, Hallbook H, Simonsson B, Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012 22961208
42. Genetic and epigenetic similarities and differences between childhood and adult AML. Juhl-Christensen C, Ommen HB, Aggerholm A, Lausen B, Kjeldsen E, Hasle H, Hokland P, Peditric blood & cancer 2012 58 525 531 10.1002/pbc.23397